(Reuters) - AbbVie ( ABBV ) raised its annual profit forecast on Thursday as strong sales of its key immunology drugs, including Humira, helped it beat Wall Street expectations for the second quarter. Sales of Humira, once the world's top-selling drug, have been declining since its close copies, or biosimilars, hit the U.S. market. There are now 10 Humira biosimilars...

07:38 AM EDT, 07/25/2024 (MT Newswires) -- Masco ( MAS ) reported Q2 adjusted net income Thursday of $1.20 per share, up from $1.19 a year earlier. Analysts polled by Capital IQ expected $1.18. Net sales for the quarter ended June 30 were $2.09 billion, down from $2.13 billion a year earlier. Analysts surveyed by Capital IQ expected $2.10 billion....

07:34 AM EDT, 07/25/2024 (MT Newswires) -- BloomZ ( BLMZ ) shares surged 24% pre-bell Thursday, rebounding from Wednesday's slump. MIRA Pharmaceuticals ( MIRA ) shares surged 43% after the company said preclinical data showed the potential benefits of Ketamir-2, a treatment candidate for neurological and neuropsychiatric disorders. Viking Therapeutics ( VKTX ) shares increased 18% after the company reported...

07:40 AM EDT, 07/25/2024 (MT Newswires) -- TechnipFMC ( FTI ) reported Q2 adjusted earnings Thursday of $0.43 per diluted share, up from $0.10 a year earlier. Analysts polled by Capital IQ expected $0.31. Revenue for the quarter ended June 30 was $2.33 billion, up from $1.97 billion a year earlier. Analysts surveyed by Capital IQ expected $2.23 billion. TechnipFMC...